In a previous 52-wk trial, treatment with alglucosidase alfa markedly improved cardiomyopathy, ventilatory function, and overall survival among 18 children <7 mo old with infantile-onset Pompe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback